Overview
Since 20 September 2021 self-declared 'non-commercial organisations' are no longer required to provide a lobby budget. See above timeline for this registrant's historical lobby budget.
Lobbying Costs
None declared
Financial year: Jan 2024 - Dec 2024
Lobbyists (Full time equivalent)
3.55 Fte (8)
Lobbyists with EP accreditation
0
High-level Commission meetings
0
Lobbying Costs over the years
-
Info
Institut National du Cancer (INC)
EU Transparency Register
627490337969-58 First registered on 29 Apr 2020
Goals / Remit
The goals of the INC are:
- coordinate and reinforce all actions in the fight against cancer,
- to facilitate access for people with cancer, wherever they are treated in the country, whatever the stage of their disease and the complexity of their treatment, to a structured, standardised, high-quality clinical and care pathway, incorporating the latest scientific data and international best practice, in complete safety,
- to develop and monitor joint initiatives with public and private cancer operators in the fields of prevention, screening, care, research, teaching, epidemiology and surveillance,
- contribute to controlling healthcare expenditure in the field of oncology.Main EU files targeted
The INC currently acts as the Competent Authority ("Beneficiary"), mandated by the Ministry of Health and Social Security of Luxembourg, in two projects of the EU4Health Programme: JA CraNE (https://crane4health.eu) and CSA ECHOS (https://cancermissionhubs.eu), as well as an Affiliated Entity in the project CSA CCI4EU (http://cci4eu.eu). In addition, the INC acts as the Competent Authority in two additional projects of the EU4Health Programme: "EU Network of the CCC/I" and the "New Network of Expertise", as of october 2024. To this end, the INC is actively involved in the consultations of the Member States' representatives in the domain of cancer.
Additionally, the director of the INC participates in the meetings of the Sub-group on Cancer under the Public Health Expert Group, operated by the DG SANTE.
Moreover, the INC provides feedback on the working documents and programmes linked to "Europe's Beating Cancer Plan" and 'European Mission on Cancer".Address
Head Office
1B, rue Thomas Edison
Strassen L-1445
LUXEMBOURGEU Office
1B, rue Thomas Edison
Strassen L-1445
LUXEMBOURGWebsite
-
People
Total lobbyists declared
8
Employment time Lobbyists 100% 2 50% 2 25% 1 10% 3 Lobbyists (Full time equivalent)
3.55
Lobbyists with EP accreditation
No lobbyists with EP accreditations
Complementary Information
Some of the activities represent unpaid contributions in kind to various projects and initiatives
Person in charge of EU relations
Data not provided by Register Secretariat due to GDPR
Person with legal responsibility
Data not provided by Register Secretariat due to GDPR
-
Categories
Category
Other organisations, public or mixed entities
-
Networking
Affiliation
Organisation of European Cancer Institutes (OECI): https://www.oeci.eu
European Cancer Organisation (ECO): https://www.europeancancer.orgMember organisations
The administrators of the Board of Directors (Conseil d’Administration) represent the founding members of the INC:
- Centre Hospitalier de Luxembourg (CHL): https://www.chl.lu;
- Centre Hospitalier Emile Mayrisch (CHEM): https://www.chem.lu;
- Hôpitaux Robert Schuman (HRS): https://www.hopitauxschuman.lu;
- Centre Hospitalier du Nord (CHdN): https://www.chdn.lu;
- Centre François Baclesse (CFB): https://www.baclesse.lu;
- Société Luxembourgeoise d’Oncologie (SLO): https://www.slo.lu;
- Fondation Cancer: https://www.cancer.lu;
- Fondatioun Kriibskrank Kanner: https://fondatioun.lu;
- Patiente Vertriedung: https://www.patientevertriedung.lu;
- Médiateur de la Santé: https://mediateursante.public.lu;
- National Cancer Platform: https://legilux.public.lu/eli/etat/leg/rgc/2021/01/22/a78/jo
as well as an observer representing the Ministry of Health of Luxembourg: https://m3s.gouvernement.lu/fr.html.
Overview:
http://institutnationalducancer.lu/inc-organisation-collaborators/#ca -
Financial Data
Interests represented
Does not represent commercial interests
Closed financial year
Jan 2024 - Dec 2024
Lobbying costs for closed financial year
Since 20 September 2021 self-declared 'non-commercial organisations' are no longer required to provide a lobby budget. See above timeline for this registrant's historical lobby budget.
Total organisational budget in closed year
2,676,716€
Major funding types in closed year
Member's contributions, Public funding, EU funding
Major contributions in closed year
Type Name Amount Contribution Ministry of Health, G.D. of Luxembourg 1,794,396€ Grant CSA ECHoS 87,150€ Grant JA CraNE, EU4Health, European Commission 92,929€ Grant CSA CCI4EU 30,549€ Grant JA EUnetCCC, EU4Health, European Commission 360,278€ Other financial info
None declared
-
EU Structures
Groups (European Commission)
None declared
Groups (European Parliament)
Cancer
Communication activities
With respect to existing policies and recommendations issued by various EU organisations and entities, the INC oversees the coordination and implementation of a subset of these measures at the national level under the mandate of the Ministry of Health and Social Security of Luxembourg.
Concerning the national policies, the INC is involved in implementing numerous measures and actions of the second National Cancer Plan 2020-2026 of Luxembourg. This includes developing and publishing national guidelines and recommendations, preparing and publishing national reports and statistics, and organising consultative meetings and conferences in the domains of oncology, patient care and support, and digitalisation.
Moreover, the INC organises national communication activities in the context of collaborative EU projects (EU4Health programme) in which it participates.Other activities
None declared
Meetings
Meetings
None declared